Cargando…

Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol

BACKGROUND: Lung cancer screening in high-risk population increases the proportion of patients diagnosed at a resectable stage. AIMS: To optimize the selection criteria and quality indicators for lung cancer screening by low-dose CT (LDCT) in the Czech population of high-risk individuals. To compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Lukas, Janouskova, Lenka, Novak, Matej, Bircakova, Bianka, Meckova, Zuzana, Votruba, Jiri, Michalek, Pavel, Burgetova, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870244/
https://www.ncbi.nlm.nih.gov/pubmed/33592843
http://dx.doi.org/10.1097/MD.0000000000023878
_version_ 1783648779072700416
author Lambert, Lukas
Janouskova, Lenka
Novak, Matej
Bircakova, Bianka
Meckova, Zuzana
Votruba, Jiri
Michalek, Pavel
Burgetova, Andrea
author_facet Lambert, Lukas
Janouskova, Lenka
Novak, Matej
Bircakova, Bianka
Meckova, Zuzana
Votruba, Jiri
Michalek, Pavel
Burgetova, Andrea
author_sort Lambert, Lukas
collection PubMed
description BACKGROUND: Lung cancer screening in high-risk population increases the proportion of patients diagnosed at a resectable stage. AIMS: To optimize the selection criteria and quality indicators for lung cancer screening by low-dose CT (LDCT) in the Czech population of high-risk individuals. To compare the influence of screening on the stage of lung cancer at the time of the diagnosis with the stage distribution in an unscreened population. To estimate the impact on life-years lost according to the stage-specific cancer survival and stage distribution in the screened population. To calculate the cost-effectiveness of the screening program. METHODS: Based on the evidence from large national trials - the National Lung Screening Trial in the USA (NLST), the NELSON study, the recent recommendations of the Fleischner society, the American College of Radiology, and I-ELCAP action group, we developed a protocol for a single-arm prospective study in the Czech Republic for the screening of high-risk asymptomatic individuals. The study commenced in August 2020. RESULTS: The inclusion criteria are: age 55 to 74 years; smoking: ≥30 pack-years; smoker or ex-smoker <15 years; performance status (0–1). The screening timepoints are at baseline and 1 year. The LDCT acquisition has a target CTDIvol ≤0.5mGy and effective dose ≤0.2mSv for a standard-size patient. The interpretation of findings is primarily based on nodule volumetry, volume doubling time (and related risk of malignancy). The management includes follow-up LDCT, contrast enhanced CT, PET/CT, tissue sampling. The primary outcome is the number of cancers detected at a resectable stage, secondary outcomes include the average cost per diagnosis of lung cancer, the number, cost, complications of secondary examinations, and the number of potentially important secondary findings. CONCLUSIONS: A study protocol for early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE) study using LDCT has been described.
format Online
Article
Text
id pubmed-7870244
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78702442021-02-10 Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol Lambert, Lukas Janouskova, Lenka Novak, Matej Bircakova, Bianka Meckova, Zuzana Votruba, Jiri Michalek, Pavel Burgetova, Andrea Medicine (Baltimore) 6800 BACKGROUND: Lung cancer screening in high-risk population increases the proportion of patients diagnosed at a resectable stage. AIMS: To optimize the selection criteria and quality indicators for lung cancer screening by low-dose CT (LDCT) in the Czech population of high-risk individuals. To compare the influence of screening on the stage of lung cancer at the time of the diagnosis with the stage distribution in an unscreened population. To estimate the impact on life-years lost according to the stage-specific cancer survival and stage distribution in the screened population. To calculate the cost-effectiveness of the screening program. METHODS: Based on the evidence from large national trials - the National Lung Screening Trial in the USA (NLST), the NELSON study, the recent recommendations of the Fleischner society, the American College of Radiology, and I-ELCAP action group, we developed a protocol for a single-arm prospective study in the Czech Republic for the screening of high-risk asymptomatic individuals. The study commenced in August 2020. RESULTS: The inclusion criteria are: age 55 to 74 years; smoking: ≥30 pack-years; smoker or ex-smoker <15 years; performance status (0–1). The screening timepoints are at baseline and 1 year. The LDCT acquisition has a target CTDIvol ≤0.5mGy and effective dose ≤0.2mSv for a standard-size patient. The interpretation of findings is primarily based on nodule volumetry, volume doubling time (and related risk of malignancy). The management includes follow-up LDCT, contrast enhanced CT, PET/CT, tissue sampling. The primary outcome is the number of cancers detected at a resectable stage, secondary outcomes include the average cost per diagnosis of lung cancer, the number, cost, complications of secondary examinations, and the number of potentially important secondary findings. CONCLUSIONS: A study protocol for early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE) study using LDCT has been described. Lippincott Williams & Wilkins 2021-02-05 /pmc/articles/PMC7870244/ /pubmed/33592843 http://dx.doi.org/10.1097/MD.0000000000023878 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6800
Lambert, Lukas
Janouskova, Lenka
Novak, Matej
Bircakova, Bianka
Meckova, Zuzana
Votruba, Jiri
Michalek, Pavel
Burgetova, Andrea
Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title_full Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title_fullStr Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title_full_unstemmed Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title_short Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol
title_sort early detection of lung cancer in czech high-risk asymptomatic individuals (elegance): a study protocol
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870244/
https://www.ncbi.nlm.nih.gov/pubmed/33592843
http://dx.doi.org/10.1097/MD.0000000000023878
work_keys_str_mv AT lambertlukas earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT janouskovalenka earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT novakmatej earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT bircakovabianka earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT meckovazuzana earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT votrubajiri earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT michalekpavel earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol
AT burgetovaandrea earlydetectionoflungcancerinczechhighriskasymptomaticindividualseleganceastudyprotocol